Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852325 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparative Pharmacokinetics of SHR-8068 and Ipilimumab in Healthy Chinese Men

StatusCompleted
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This phase 1 study compared the pharmacokinetics of a single intravenous dose of SHR-8068 injection with ipilimumab (YERVOY®) in healthy Chinese men. Safety and immunogenicity were also evaluated.
Trial Details
NCT Number NCT07852325
Lead Sponsor The Affiliated Hospital of Qingdao University
Collaborators: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions
(from sponsor)		 Healthy Participants
Enrollment 124 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov